The Stent Delivery Systems Market is estimated to be valued at USD 13.5 billion in 2025 and is projected to reach USD 26.6 billion by 2035, registering a compound annual growth rate (CAGR) of 7.0% over the forecast period.
The stent delivery systems market is progressing steadily due to increased demand for minimally invasive procedures and rising prevalence of cardiovascular diseases. Hospitals and healthcare providers are focusing on improving patient outcomes through advanced interventional devices that offer precise placement and reduced recovery times. The shift towards peripheral artery disease management has led to heightened adoption of specialized stent delivery systems designed to navigate complex vascular pathways.
Technological developments in device design, such as enhanced flexibility and compatibility with various stent types, have improved procedural success rates. Additionally, expanding hospital infrastructure and investment in cardiovascular care services are fueling market growth.
As healthcare systems prioritize minimally invasive treatment options, the market is expected to be driven by peripheral stent delivery systems and hospital-based applications.
The market is segmented by Type and Application and region. By Type, the market is divided into Peripheral Stent Delivery System and Vascular Stent Delivery System. In terms of Application, the market is classified into Hospital, Outpatient, Medical Equipment Supplier, and Other Applications. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The Peripheral Stent Delivery System segment is projected to hold 56.8% of the stent delivery systems market revenue in 2025, positioning it as the leading type segment. This growth can be attributed to the increasing incidence of peripheral artery disease and related complications that require effective endovascular interventions. These systems are favored for their ability to deliver stents accurately within peripheral vessels, which are often more tortuous and smaller in diameter than coronary arteries.
Improved catheter design and delivery mechanisms have enhanced navigability and deployment precision, reducing procedural risks. The segment’s expansion is also supported by growing awareness and screening for peripheral vascular conditions.
Continued innovation aimed at increasing safety and ease of use is expected to sustain the segment’s leadership.
The Hospital segment is expected to account for 64.3% of the stent delivery systems market revenue in 2025, maintaining its position as the primary application area. Hospitals are preferred for their advanced infrastructure and skilled interventional cardiology teams capable of performing complex stenting procedures. The presence of specialized catheterization laboratories and post-operative care units makes hospitals the ideal setting for stent delivery system deployment.
Increasing hospital admissions for cardiovascular interventions and expanding healthcare access in emerging regions contribute to the segment’s growth. Moreover, hospitals are central to clinical trials and adoption of new medical technologies, accelerating the uptake of innovative stent delivery systems.
As minimally invasive therapies continue to gain prominence, the hospital segment is expected to remain the dominant application environment.
The demand for stent delivery systems is increasing as it aids in the placement of stents into arteries and narrow blood channels in order to open them and guarantee appropriate blood flow. The stents are made of nickel and titanium and have a self-expanding nitinol construction, which is a primary factor responsible for growing sales of stent delivery systems.
On the stent delivery systems, the stents are preloaded. The stent delivery system is also simple to use, with a modular design and a single operator. Due to these factors the demand for stent delivery systems is anticipated to rise.
The sales of stent delivery systems is growing as it reduces friction during deployment, allowing for precise stent insertion. High operation costs and the scarcity of surgeons are two problems that may stimulate stent delivery systems market expansion.
The emergence of new technologies and advancements in stent delivery systems have resulted in a reduction in technical faults and assistance in releasing the stents at the required targets, increasing the sales of stent delivery systems and expanding the global stent delivery systems market share.
The demand for stent delivery systems is being driven by a rise in minimally invasive surgeries. One of the primary factors driving the stent delivery systems market share is the increasing prevalence of atherosclerosis and arterial diseases. The development of self-expanding stents and innovative technologies is augmenting the sales of stent delivery systems.
Rising research activity, as well as increased regulatory approvals, are some of the drivers driving the expansion of stent delivery systems market share. Some of the reasons driving the sales of stent delivery systems include an increase in the number of research activities focusing on stent delivery systems and an increase in regulatory approvals.
As healthcare improves, healthcare facilities and hospitals are shifting their attention to a more value-based system.
These stent delivery systems are also utilized on patients who are undergoing percutaneous coronary intervention procedures. These reasons encourage R&D and medical departments to overcome limitations in order to develop better alternative stent delivery systems.
Geographically, the market for stent delivery systems is divided into North America, Europe, Latin America, Asia-Pacific, Japan, and the Middle East and Africa. Due to the increasing number of patients suffering from cardiac ailments and blockages, the North American region is predicted to lead the global stent delivery systems market share, followed by Europe.
Furthermore, the availability of modern goods that replace traditional systems is increasing in the United States, which is likely to enhance the demand for Stent delivery systems in the region. The patient is made more comfortable by the new modern systems.
The Asia Pacific stent delivery systems market is predicted to grow at a faster rate due to an increasing geriatric population, which is expected to enhance the sales of stent delivery systems. Furthermore, countries in the Asia Pacific and Latin America, such as India and China, are predicted to see faster revenue growth in stent delivery systems market during the forecast period.
Boston Scientific Corporation, B. Braun Melsungen AG, Medtronic Plc., Stryker Corporation, ELLA - CS, s.r.o., Becton, Dickinson and Company, Svelte Medical, Abbott, Terumo Europe NV, and others are among the key players in the stent delivery systems market.
Furthermore, stent delivery system market manufacturers are primarily focused on enhancing and expanding the key competencies of their product range.
Recent Developments
| Report Attribute | Details |
|---|---|
| Growth rate | CAGR of 7% from 2025 to 2035 |
| Base year for estimation | 2024 |
| Historical data | 2020 to 2024 |
| Forecast period | 2025 to 2035 |
| Quantitative units | Revenue in billion, volume in kilotons and CAGR from 2025 to 2035 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors and trends, Pricing Analysis |
| Segments covered | Product type, Indications, End user, region |
| Regional scope | North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia; Australia and New Zealand |
| Country scope | USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
| Key companies profiled | Boston Scientific Corporation; B. Braun Melsungen AG; Medtronic Plc.; Stryker Corporation; ELLA - CS; s.r.o.; Becton; Dickinson and Company; Svelte Medical; Abbott; Terumo Europe NV |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
The global stent delivery systems market is estimated to be valued at USD 13.5 billion in 2025.
It is projected to reach USD 26.6 billion by 2035.
The market is expected to grow at a 7.0% CAGR between 2025 and 2035.
The key product types are peripheral stent delivery system and vascular stent delivery system.
hospital segment is expected to dominate with a 64.3% industry share in 2025.
Explore Similar Insights
Stent Delivery Systems Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
